Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amarin Corporation plc - American Depositary Shares
(NQ:
AMRN
)
16.26
-0.25 (-1.51%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amarin Corporation plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
January 09, 2026
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
January 08, 2026
U.S. IPE Market Leadership Sustained; $70M Restructuring OPEX Savings on Pace for Mid-2026; Completed Transition to Fully Partnered Model Across All International Markets
From
Amarin Corporation plc
Via
GlobeNewswire
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
Earnings Outlook For Amarin Corp
↗
October 28, 2025
Via
Benzinga
Earnings Scheduled For July 30, 2025
↗
July 30, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
Exploring Amarin Corp's Earnings Expectations
↗
May 06, 2025
Via
Benzinga
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
November 09, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
November 03, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Corp (NASDAQ:AMRN) Beats Q3 2025 Earnings and Revenue Estimates
↗
October 29, 2025
Amarin (AMRN) Q3 2025 earnings beat expectations with strong revenue growth and a narrowed loss, driven by its new global partner strategy.
Via
Chartmill
Topics
Earnings
Amarin Reports Third Quarter 2025 Financial Results
October 29, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
October 27, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
October 15, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
October 14, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
August 31, 2025
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --
From
Amarin Corporation plc
Via
GlobeNewswire
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
August 30, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
August 25, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Reports Second Quarter 2025 Financial Results
July 30, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025
July 23, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA
↗
June 24, 2025
Amarin Corporation (NASDAQ: AMRN) shares are trading higher Tuesday after the company announced a long-term exclusive license and supply agreement with Recordati S.p.A. to commercialize its...
Via
Benzinga
Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges
↗
June 24, 2025
Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to improve cash flow
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 24, 2025
Via
Benzinga
Which stocks are gapping on Tuesday?
↗
June 24, 2025
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
June 24, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Reports First Quarter 2025 Financial Results
May 07, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 02, 2025
Via
Benzinga
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 29, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
April 28, 2025
From
Amarin Corporation plc
Via
GlobeNewswire
Top 2 Health Care Stocks That May Crash This Month
↗
April 25, 2025
Via
Benzinga
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
↗
April 14, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
